Ustekinumab in Hidradenitis Suppurativa: A Systematic Review and Meta-analysis

• Main Authors: Rahul Masson (Author), Justine Seivright (Author), Tristan Grogan (Author), Swetha Atluri (Author), Iltefat Hamzavi (Author), Marcia Hogeling (Author), Vivian Y. Shi (Author), Jennifer L. Hsiao (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Hidradenitis suppurativa (HS) is a frequently debilitating, inflammatory skin condition. Patients may have a limited response to adalimumab, currently the only Food and Drug Administration (FDA)-approved biologic treatment for HS. Ustekinumab is an interleukin-12/23 inhibitor t...